Carvedilol

Carvedilol (CAS 72956-09-3, Form II polymorph) is manufactured directly by Polpharma in pharmaceutical grade to EP standard, with a long track record of in-house commercial manufacturing, tailored particle size distribution, and DMF readiness across EU, Japan, Korea, and the US along with CEP certification. A beta-blocker used to treat heart failure, hypertension, and reduced cardiac pumping function following a heart attack, it is supplied on a commercial basis; note that in countries where it remains patent-protected (e.g., Poland), the supplier offers it only for regulatory submission or R&D purposes, with patent clearance the buyer's responsibility. It is sold across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.